GENESYS™
Delivery Platform

Pegylated Lipid
 
DOPC
 
Orion Lipopeptide
 
Cholesterol
 
 

The Orion GENESYS™ Platform

The GENESYS™ Delivery Platform incorporates bioinspired lipopeptides, while entirely excluding ionizable cationic lipids, for effective RNA therapy delivery

Frame
Bio-inspired Design
Drawing inspiration from natural biological processes, our lipopeptide technology enhances cellular uptake and targeting
Group
Enhanced Cellular Uptake
We utilize optimized lipopeptide formulations that improve the efficiency of cellular entry, ensuring high uptake rates of RNA
Frame (1)
Reduced Immunogenicity
Carefully engineered components lower the potential for immune activation as compared to ionizable LNPs, promoting safer clinical profiles
target
Targeted Delivery
Our precise targeting allows for direct delivery to specific cell types, minimizing off-target effects and maximizing therapeutic efficacy
Frame (1)
Scalable Production
We incorporate state-of-the-art microfluidic technologies that guarantee consistent nanoparticle quality and scalability
Group
Intellectual Property Protection
Our patent portfolio covers lipopeptide-based compositions, formulation processes and targeted delivery

In The Press

Partnering

Interested to learn more?